Angiogenesis in diabetes and obesity

The prevalence of diabetes mellitus and obesity continues to increase globally. Diabetic vascular complications are the main chronic diabetic complications and associated with mortality and disability. Angiogenesis is a key pathological characteristic of diabetic microvascular complications. However, there are two tissue-specific paradoxical changes in the angiogenesis in diabetic microvascular complications: an excessive uncontrolled formation of premature blood vessels in some tissues, such as the retina, and a deficiency in the formation of small blood vessels in peripheral tissues, such as the skin. This review will discuss the paradoxical phenomena of angiogenesis and its underlying mechanism in obesity, diabetes and diabetic complications.

[1]  F. Siemers,et al.  Wnt signaling induces epithelial differentiation during cutaneous wound healing , 2015, Organogenesis.

[2]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[4]  Michael H. Elliott,et al.  Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage , 2010, Diabetes.

[5]  V. Mohan,et al.  Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. , 2012, Journal of diabetes and its complications.

[6]  Yihai Cao.  Angiogenesis modulates adipogenesis and obesity. , 2007, The Journal of clinical investigation.

[7]  E. Wawrousek,et al.  alphaB-crystallin regulation of angiogenesis by modulation of VEGF. , 2010, Blood.

[8]  Ying Chen,et al.  Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy , 2012, Diabetes.

[9]  Christian Schmidt,et al.  NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity , 2004, Molecular and Cellular Biology.

[10]  T. Pawson,et al.  Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. , 2013, Cell metabolism.

[11]  Jan Nedergaard,et al.  Brown adipose tissue: function and physiological significance. , 2004, Physiological reviews.

[12]  J. Pouysségur,et al.  Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors. , 2005, Cardiovascular research.

[13]  L. Chao,et al.  Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy. , 1996, Current eye research.

[14]  P. Sucharda,et al.  Angiogenic factors are elevated in overweight and obese individuals , 2005, International Journal of Obesity.

[15]  H. Lijnen,et al.  Deficiency of thrombospondin‐1 in mice does not affect adipose tissue development , 2006, Journal of thrombosis and haemostasis : JTH.

[16]  T. Zhou,et al.  Identification of a Novel Inhibitor of the Canonical Wnt Pathway , 2011, Molecular and Cellular Biology.

[17]  M. Matsumura,et al.  Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. , 2002, American journal of ophthalmology.

[18]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[19]  O. Stojadinović,et al.  Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. , 2009, Journal of Investigative Dermatology.

[20]  E. Crivellato,et al.  Erythropoietin as an angiogenic factor , 2003, European journal of clinical investigation.

[21]  D. V. Vander Jagt,et al.  Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. , 2002, Investigative ophthalmology & visual science.

[22]  H. Yamashita,et al.  Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. , 2005, Ophthalmology.

[23]  H. Lijnen,et al.  Matrix metalloproteinase inhibition impairs murine adipose tissue development independently of leptin. , 2011, Endocrine journal.

[24]  Yang Hu,et al.  Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. , 2011, The American journal of pathology.

[25]  M. Czech,et al.  Depot-Specific Differences and Insufficient Subcutaneous Adipose Tissue Angiogenesis in Human Obesity , 2011, Circulation.

[26]  D. Collen,et al.  Effect of matrix metalloproteinase inhibition on adipose tissue development. , 2005, Biochemical and biophysical research communications.

[27]  C. Barnstable,et al.  PEDF: a multifaceted neurotrophic factor , 2003, Nature Reviews Neuroscience.

[28]  Jan Nedergaard,et al.  The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  H. Yamashita,et al.  Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. , 2006, Ophthalmology.

[30]  N. Bressler,et al.  A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. , 2007, Ophthalmology.

[31]  Xiaodong Feng,et al.  Angiogenesis in wound healing. , 2000, The journal of investigative dermatology. Symposium proceedings.

[32]  Va Puget,et al.  Preventing foot ulcers in patients with diabetes , 2005 .

[33]  M. Boulton,et al.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. , 2009, The American journal of pathology.

[34]  R. Hamlin,et al.  Capillary Basement Membrane Thickness and Capillary Density in Sedentary and Trained Obese Zucker Rats , 1989, Diabetes.

[35]  J. Ye.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance , 2009, International Journal of Obesity.

[36]  A. Knox,et al.  Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). , 2008, The Journal of biological chemistry.

[37]  H. Yamashita,et al.  Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. , 2003, Ophthalmology.

[38]  B. S. Srivastava,et al.  Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. , 1998, Biochemical and biophysical research communications.

[39]  T. Imaizumi,et al.  Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[40]  N. Sonenberg,et al.  Ablation of 4E-BP1/2 Prevents Hyperglycemia-Mediated Induction of VEGF Expression in the Rodent Retina and in Müller Cells in Culture , 2010, Diabetes.

[41]  C. Harper,et al.  Increased serum pigment epithelium‐derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes 1 , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[42]  J. Lawler,et al.  Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth , 2002, Journal of cellular and molecular medicine.

[43]  Bohan Wang,et al.  Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes , 2007, Pflügers Archiv - European Journal of Physiology.

[44]  J. Pfeilschifter,et al.  Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  S. McDougall,et al.  Dynamics of Angiogenesis During Wound Healing: A Coupled In Vivo and In Silico Study , 2011, Microcirculation.

[46]  A. Jenkins,et al.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. , 2014, Journal of diabetes and its complications.

[47]  P. Riederer,et al.  High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expression , 1999 .

[48]  G. Gao,et al.  Kallikrein-binding protein suppresses growth of hepatocellular carcinoma by anti-angiogenic activity. , 2007, Cancer letters.

[49]  Hyung Chan Kim,et al.  PANRETINAL PHOTOCOAGULATION COMBINED WITH INTRAVITREAL BEVACIZUMAB IN HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY , 2009, Retina.

[50]  Hyung Chan Kim,et al.  Hyung Chan Kim photocoagulation in diabetic retinopathy adjunctive treatments to panretinal Intravitreal triamcinolone and bevacizumab as , 2009 .

[51]  K. Nishida,et al.  Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy , 2009, Diabetologia.

[52]  D. Rosberger.  Diabetic retinopathy: current concepts and emerging therapy. , 2013, Endocrinology and metabolism clinics of North America.

[53]  Consensus development conference on diabetic foot wound care. 7-8 April 1999, Boston, MA. American Diabetes Association , 1999, Advances in wound care : the journal for prevention and healing.

[54]  W. Jia,et al.  Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. , 2008, American journal of physiology. Endocrinology and metabolism.

[55]  R. Simó,et al.  Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy , 1997, Diabetologia.

[56]  D. James,et al.  Pigment epithelium-derived factor contributes to insulin resistance in obesity. , 2009, Cell metabolism.

[57]  V. Notario,et al.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential , 2013, Nature Reviews Cancer.

[58]  Li Yan,et al.  Involvement of RAGE, MAPK and NF‐κB pathways in AGEs‐induced MMP‐9 activation in HaCaT keratinocytes , 2012, Experimental dermatology.

[59]  K. Zhou,et al.  Antiangiogenic and Antineuroinflammatory Effects of Kallistatin Through Interactions With the Canonical Wnt Pathway , 2013, Diabetes.

[60]  Jianping Ye,et al.  Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[61]  D. Chung,et al.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. , 2001, Cancer research.

[62]  Y. Shin,et al.  Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy , 2009, Korean journal of ophthalmology : KJO.

[63]  W. D. van Marken Lichtenbelt,et al.  Brown Adipose Tissue in Morbidly Obese Subjects , 2011, PloS one.

[64]  Y. Tsao,et al.  PEDF promotes self‐renewal of limbal stem cell and accelerates corneal epithelial wound healing , 2013, Stem cells.

[65]  V. Sukhatme,et al.  Endostatin is a potential inhibitor of Wnt signaling , 2002, The Journal of cell biology.

[66]  Sharon D. Solomon,et al.  VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy , 2013, Diabetes.

[67]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[68]  R. Jain,et al.  Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells , 2009, PloS one.

[69]  Jian-xing Ma,et al.  Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization , 2001, FEBS letters.

[70]  Geoffrey C Gurtner,et al.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. , 2004, The American journal of pathology.

[71]  N. Bressler,et al.  Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. , 2013, JAMA ophthalmology.

[72]  M. Feldmann,et al.  VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor IκBα and a kinase-defective form of the IκB kinase 2 , 2003, Journal of Cell Science.

[73]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[74]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[75]  J. Tombran-Tink,et al.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.

[76]  F. Cipollone,et al.  Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[77]  G. Karakiulakis,et al.  Vitreous and serum levels of vascular endothelial growth factor and platelet‐derived growth factor and their correlation in patients with non‐proliferative diabetic retinopathy and clinically significant macula oedema , 2011, Acta ophthalmologica.

[78]  P. Trayhurn.  Hypoxia and adipose tissue function and dysfunction in obesity. , 2013, Physiological reviews.

[79]  David G Armstrong,et al.  Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. , 2003, Diabetes care.

[80]  G. Gao,et al.  Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. , 2006, Journal of molecular endocrinology.

[81]  H. Lijnen,et al.  Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[82]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[83]  A. Jenkins,et al.  Elevated Circulation Levels of an Anti-angiogenic SERPIN in Patients with Diabetic Microvascular Complications Impairs Wound Healing through Suppression of Wnt Signaling , 2014, The Journal of investigative dermatology.

[84]  T. Zhou,et al.  Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: A novel mechanistic insight into progressive obesity , 2013, Molecular and Cellular Endocrinology.

[85]  B. Barlogie,et al.  International Prognostic Scoring System (IPSS) for Waldenström’s Macroglobulinemia (WM). , 2006 .

[86]  W. T. Cade,et al.  Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting , 2008, Physical Therapy.

[87]  R. Evans,et al.  Augmented expression and secretion of adipose-derived pigment epithelium-derived factor does not alter local angiogenesis or contribute to the development of systemic metabolic derangements. , 2014, American journal of physiology. Endocrinology and metabolism.

[88]  S. Pedersen.  Metabolic complications of obesity. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[89]  W D van Marken Lichtenbelt,et al.  Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. , 2012, The Journal of clinical endocrinology and metabolism.

[90]  Shu-Yun Le,et al.  Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription , 1998, Oncogene.

[91]  R. Soares,et al.  Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. , 2013, Life sciences.

[92]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[93]  U. Schmidt-Erfurth,et al.  Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation , 2011, Acta ophthalmologica.

[94]  G. Semenza,et al.  Regulation of angiogenesis by hypoxia-inducible factor 1. , 2006, Critical reviews in oncology/hematology.

[95]  L. Westerkamp,et al.  Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. , 2005, Journal of applied physiology.

[96]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[97]  R. A. Mahdy,et al.  The role of vascular endothelial growth factor in the progression of diabetic vascular complications , 2010, Eye.

[98]  S. Bir,et al.  Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing , 2012, International journal of vascular medicine.

[99]  S. Coppack,et al.  Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.

[100]  Xun Xu,et al.  Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy. , 2011, American journal of ophthalmology.

[101]  T. Lyons,et al.  Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. , 2008, Journal of molecular endocrinology.

[102]  D. Thompson,et al.  Elevated plasma pigment epithelium‐derived factor in children with type 2 diabetes mellitus is attributable to obesity , 2015, Pediatric diabetes.

[103]  K. Channon,et al.  Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes. , 2009, American journal of physiology. Endocrinology and metabolism.

[104]  B. Detrick,et al.  Regulation of VEGF expression in human retinal cells by cytokines: Implications for the role of inflammation in age‐related macular degeneration , 2012, Journal of cellular physiology.

[105]  Elaine Fuchs,et al.  Skin Stem Cells Orchestrate Directional Migration by Regulating Microtubule-ACF7 Connections through GSK3β , 2011, Cell.

[106]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[107]  Suyun Huang,et al.  Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. , 2010, Oncology reports.

[108]  E. Mariman,et al.  Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot. , 2008, European journal of endocrinology.

[109]  F Vinicor,et al.  The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.

[110]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.

[111]  N. Ferrara.  Role of vascular endothelial growth factor in regulation of physiological angiogenesis. , 2001, American journal of physiology. Cell physiology.

[112]  Yeong-Rim Kang,et al.  Platelet‐activating factor‐induced NF‐κB activation enhances VEGF expression through a decrease in p53 activity , 2006, FEBS letters.

[113]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[114]  Yihai Cao.  Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases , 2010, Nature Reviews Drug Discovery.

[115]  J. Gilbert,et al.  Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. , 2007, Ophthalmology.

[116]  J. Tombran-Tink,et al.  Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. , 1989, Investigative ophthalmology & visual science.

[117]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[118]  A. Calle-Pascual,et al.  Epidemiology of nontraumatic lower-extremity amputation in area 7, Madrid, between 1989 and 1999: a population-based study. , 2001, Diabetes care.

[119]  J. Ji.  Pigment epithelium derived factor:a potent inhibitor of angiogenesis , 2002 .

[120]  T. Mimura,et al.  Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. , 2009, Ophthalmology.

[121]  N. Koçak,et al.  Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases. , 2010, Annals of ophthalmology.

[122]  Yihai Cao,et al.  Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice , 2004, Circulation research.

[123]  E. Ravussin,et al.  Brown Adipose Tissue: Mechanisms and Potential Therapeutic Targets , 2012, Circulation.

[124]  G. Ruggeri,et al.  Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy. , 2014, Diabetes & metabolism.

[125]  Lee Chao,et al.  Kallistatin is a new inhibitor of angiogenesis and tumor growth. , 2002, Blood.

[126]  B. Wolffenbuttel,et al.  Characterization of the Human Visceral Adipose Tissue Secretome*S , 2007, Molecular & Cellular Proteomics.

[127]  Suyun Huang,et al.  Constitutive and inducible expression and regulation of vascular endothelial growth factor. , 2004, Cytokine & growth factor reviews.

[128]  G. Gao,et al.  Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis , 2007, Molecular Cancer Therapeutics.

[129]  Y. Le,et al.  Müller cell‐derived VEGF is a significant contributor to retinal neovascularization , 2009, The Journal of pathology.

[130]  T. Fujikado,et al.  Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. , 2009, Ophthalmology.

[131]  Leanne M. Redman,et al.  Reduced adipose tissue oxygenation in human obesity evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response , 2008 .

[132]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[133]  D. Shima,et al.  The Mouse Gene for Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[134]  C. Corless,et al.  Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells , 2011, Diabetologia.

[135]  L. Chao,et al.  Localization and Expression of Tissue Kallikrein and Kallistatin in Human Blood Vessels , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[136]  J. Helms,et al.  Wnt signaling and injury repair. , 2012, Cold Spring Harbor perspectives in biology.

[137]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[138]  S. Weiss,et al.  Pigment epithelium-derived growth factor: modulating adult neural stem cell self-renewal , 2009, Nature Neuroscience.

[139]  K. Suzuma,et al.  Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. , 2005, American journal of ophthalmology.

[140]  C. Peterson,et al.  Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. , 2011, The Journal of clinical endocrinology and metabolism.

[141]  T. Zhou,et al.  High Levels of Pigment Epithelium–Derived Factor in Diabetes Impair Wound Healing Through Suppression of Wnt Signaling , 2014, Diabetes.

[142]  R. Simó,et al.  Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. , 2001, Diabetes care.

[143]  Philip Bao,et al.  The role of vascular endothelial growth factor in wound healing. , 2009, The Journal of surgical research.

[144]  L. Chao,et al.  Identification of a new tissue-kallikrein-binding protein. , 1986, The Biochemical journal.

[145]  D. Sane,et al.  Abnormal angiogenesis in diabetes mellitus , 2003, Medicinal research reviews.

[146]  N. Perrimon,et al.  The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.

[147]  N. Perrimon,et al.  The promise and perils of Wnt signaling through beta-catenin. , 2002, Science.

[148]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[149]  W. D. van Marken Lichtenbelt,et al.  Cold-activated brown adipose tissue in healthy men. , 2009, The New England journal of medicine.

[150]  V. Christiaens,et al.  Angiogenesis and development of adipose tissue , 2010, Molecular and Cellular Endocrinology.

[151]  A. Keh,et al.  Ultrastructural analysis of the endothelial-pericyte relationship in diabetic cutaneous vessels. , 1990, The Journal of investigative dermatology.